openPR Logo

Press Releases from DelveInsight Business Research (5349 total)

Esophageal Cancer Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Esophageal Cancer pipeline constitutes 80+ key companies continuously working towards developing 80+ Esophageal Cancer

Tyrosine Kinase 2 (TYK2) Inhibitors Pipeline Assessment, 2023 Updates | In-depth …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Tyrosine Kinase 2 (TYK2) Inhibitors pipeline constitutes 15+ key companies continuously working towards developing

Assessing Huntington's Disease Pipeline: Clinical Trials, Drug Evolution through …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Huntington's Disease pipeline constitutes 50+ key companies continuously working towards developing 50+ Huntington's Disease treatment

NASH (Nonalcoholic Steatohepatitis) Market 2032: Treatment Trends, FDA Approvals …

(Albany, USA) DelveInsight's "Nonalcoholic Steatohepatitis (NASH) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Nonalcoholic Steatohepatitis (NASH), historical and forecasted epidemiology

Cancer Cachexia Market Insights - Therapeutic Approvals, Epidemiology, Leading C …

(Albany, USA) DelveInsight's "Cancer Cachexia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Cancer Cachexia, historical and forecasted epidemiology as well

Peripheral T Cell Lymphomas Pipeline Analysis, 2023 Updates | Latest FDA, EMA, a …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Peripheral T Cell Lymphomas pipeline constitutes 40+ key companies continuously working towards developing 40+

Generalized Anxiety Disorder Pipeline Analysis, 2023 Updates | Latest FDA, EMA, …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Generalized Anxiety Disorder pipeline constitutes 10+ key companies continuously working towards developing 12+ Generalized

Testicular Cancer Pipeline Assessment, 2023 Updates | In-depth Insights into the …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Testicular Cancer pipeline constitutes 5+ key companies continuously working towards developing 5+ Testicular Cancer

Cnnabinoid Receptor Type 2 (CB2) Agonist Pipeline Assessment, 2023 Updates: FDA, …

Cnnabinoid Receptor Type 2 (CB2) Agonist Pipeline Assessment, 2023 Updates: FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, Therapeutic Analysis, and Growth Prospects |

Chronic Inflammatory Demyelinating Polyneuropathy Market to Exhibit Rapid Growth …

DelveInsight's "Chronic Inflammatory Demyelinating Polyneuropathy Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Chronic Inflammatory Demyelinating Polyneuropathy, historical and forecasted

Myc Proto Oncogene Protein Pipeline Assessment, 2023 Updates | In-depth Insights …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Myc Proto Oncogene Protein pipeline constitutes key companies continuously working towards developing Myc Proto

Opioid Dependence Pipeline and Clinical Trials Assessment 2023: FDA Approvals, T …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Opioid Dependence pipeline constitutes 35+ key companies continuously working towards developing 40+ Opioid Dependence

Facioscapulohumeral Muscular Dystrophy Pipeline Drugs Analysis Report, 2023: FDA …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Facioscapulohumeral Muscular Dystrophy pipeline constitutes 10+ key companies continuously working towards developing 10+ Facioscapulohumeral

Diabetic Retinopathy Market Trends in 2032 - Treatment Advancements, FDA Approva …

(Albany, USA) DelveInsight's "Diabetic retinopathy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Diabetic retinopathy, historical and forecasted epidemiology as well

DelveInsight's Analyses Interstitial Cystitis Pipeline 2023 - FDA Approvals, Cli …

(Albany, USA) DelveInsight's, "Interstitial Cystitis Pipeline Insight, 2023," report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Interstitial Cystitis pipeline landscape. It

Comprehensive Analysis of Pre-Eclampsia Pipeline Drugs (2023 Update): FDA Approv …

(Albany, USA) DelveInsight's 'Pre-Eclampsia Pipeline Insight 2023' report provides comprehensive global coverage of available, marketed, and pipeline Pre-Eclampsia therapies in various stages of clinical development,

Schizophrenia Market 2032: Epidemiology, Treatment Trends, Clinical Trials, FDA …

(New York, USA) DelveInsight's "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Schizophrenia, historical and forecasted epidemiology as well as

Global Interbody Cages Market Is Estimated To Grow At A CAGR Of 4.72% During 202 …

(New York, USA) DelveInsight's 'Interbody Cages Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Interbody Cages and the historical

Alagille Syndrome Market Forecasted for Significant Growth by 2032, as per Delve …

(Albany, USA) DelveInsight's "Alagille Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Alagille Syndrome, historical and forecasted epidemiology as well

Head and Neck Cancer Pipeline Analysis Report by DelveInsight | Investigating FD …

(New York, USA) DelveInsight's 'Head and Neck Cancer Pipeline Insight 2023' report provides comprehensive global coverage of available, marketed, and pipeline head and neck cancer

Latest Updates on Hearing Loss Clinical Trials 2023: FDA Approvals, Therapies, T …

(New York, USA) DelveInsight's 'Hearing Loss Pipeline Insight 2023' report provides comprehensive global coverage of available, marketed, and pipeline hearing loss therapies in various stages

Cystinosis Pipeline and Clinical Trials 2023: Latest FDA Approvals, Therapeutic …

(New York, USA) DelveInsight's 'Cystinosis Pipeline Insight 2023' report provides comprehensive global coverage of available, marketed, and pipeline Cystinosis therapies in various stages of clinical

Epidermolysis Bullosa Pipeline, Clinical Trials, FDA Approvals, Treatment Market …

(Las Vegas, Nevada, United States) "Epidermolysis Bullosa Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects

TCR-Therapy Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, TCR-Therapy pipeline constitutes 30+ key companies continuously working towards developing 100+ TCR-Therapy treatment therapies,

Myasthenia Gravis Pipeline Analysis, 2023 Updates | Latest FDA, EMA, and PMDA Ap …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Myasthenia Gravis pipeline constitutes 20+ key companies continuously working towards developing 20+ Myasthenia Gravis

Acromegaly Pipeline Assessment, 2023 Updates: FDA, EMA, and PMDA Approvals, Emer …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Acromegaly pipeline constitutes 12+ key companies continuously working towards developing 13+ Acromegaly treatment therapies,

Fibrodysplasia Ossificans Progressiva Market to Exhibit Rapid Growth Rate During …

DelveInsight's "Fibrodysplasia Ossificans Progressiva Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Fibrodysplasia Ossificans Progressiva, historical and forecasted epidemiology as

Angelman Syndrome Pipeline Assessment, 2023 Updates: FDA, EMA, and PMDA Approval …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Angelman Syndrome pipeline constitutes 10+ key companies continuously working towards developing 10+ Angelman Syndrome

Charcot Marie Tooth Disease Pipeline Drugs Analysis Report (2023 Updates): FDA A …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Charcot Marie Tooth Disease pipeline constitutes 10+ key companies continuously working towards developing 10+

Polymyositis Market and Epidemiology 2032: Treatment Market, Therapies, Companie …

DelveInsight's "Polymyositis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Polymyositis, historical and forecasted epidemiology as well as the Polymyositis

Neuroblastoma Market to Register Incremental Growth During the Forecast Period ( …

DelveInsight's "Neuroblastoma Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Neuroblastoma, historical and forecasted epidemiology as well as the Neuroblastoma

Wet Age-Related Macular Degeneration Pipeline Drugs Analysis Report (2023 Update …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Wet Age-Related Macular Degeneration pipeline constitutes 75+ key companies continuously working towards developing 80+

Type 2 Diabetes Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical Tr …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Type 2 Diabetes pipeline constitutes 100+ key companies continuously working towards developing 100+ Type

Multiple Sclerosis Pipeline Assessment, 2023 Updates: FDA, EMA, and PMDA Approva …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Multiple Sclerosis pipeline constitutes 100+ key companies continuously working towards developing 100+ Multiple Sclerosis

Dilated Cardiomyopathy Pipeline Analysis, 2023 Updates | Latest FDA, EMA, and PM …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Dilated Cardiomyopathy pipeline constitutes 10+ key companies continuously working towards developing 10+ Dilated Cardiomyopathy

Vasculitis Pipeline and Clinical Trials Assessment 2023: FDA Approvals, Therapie …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Vasculitis pipeline constitutes 20+ key companies continuously working towards developing 30+ Vasculitis treatment therapies,

Stargardt Disease Pipeline Drugs Analysis Report (2023 Updates): FDA Approvals, …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Stargardt Disease pipeline constitutes 18+ key companies continuously working towards developing 20+ Stargardt Disease

Essential Thrombocythemia Pipeline Drugs Analysis Report, 2023: FDA Approvals, C …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Essential Thrombocythemia pipeline constitutes 6+ key companies continuously working towards developing 6+ Essential Thrombocythemia

Chemotherapy-Induced Diarrhea Market to Exhibit Rapid Growth Rate During the For …

DelveInsight's "Chemotherapy-Induced Diarrhea Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Chemotherapy-Induced Diarrhea, historical and forecasted epidemiology as well as

Traumatic Brain Injury Pipeline Analysis, 2023 Updates | Latest FDA, EMA, and PM …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Traumatic Brain Injury pipeline constitutes key companies continuously working towards developing Traumatic Brain Injury

Prostate Cancer Pipeline Drugs Analysis Report (2023 Updates): FDA Approvals, Cl …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Prostate Cancer pipeline constitutes 200+ key companies continuously working towards developing 200+ Prostate Cancer

Bronchiolitis Obliterans Syndrome Pipeline Assessment, 2023 Updates: FDA, EMA, a …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Bronchiolitis Obliterans Syndrome pipeline constitutes 5+ key companies continuously working towards developing 5+ Bronchiolitis

P2X7 Receptor Antagonist Pipeline and Clinical Trials Assessment 2023: FDA Appro …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, P2X7 Receptor Antagonist pipeline constitutes key companies continuously working towards developing P2X7 Receptor Antagonist

Wilson Disease Pipeline Assessment, 2023 Updates: FDA, EMA, and PMDA Approvals, …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Wilson Disease pipeline constitutes 5+ key companies continuously working towards developing 5+ Wilson Disease

T-cell receptor (TCR) Therapy Pipeline Drugs Analysis Report, 2023: FDA Approval …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, T-cell receptor (TCR) Therapy pipeline constitutes key companies continuously working towards developing T-cell receptor

Hypoxia Pipeline Drugs Analysis Report (2023 Updates): FDA Approvals, Clinical T …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hypoxia pipeline constitutes key companies continuously working towards developing Hypoxia treatment therapies, analysis of

Pre-Eclampsia Pipeline Assessment, 2023 Updates: FDA, EMA, and PMDA Approvals, E …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Pre-Eclampsia pipeline constitutes 5+ key companies continuously working towards developing 5+ Pre-Eclampsia treatment therapies,

Lyme Disease Pipeline Analysis, 2023 Updates | Latest FDA, EMA, and PMDA Approva …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Lyme Disease pipeline constitutes 7+ key companies continuously working towards developing 7+ Lyme Disease

Metastatic Colorectal Cancer Pipeline Drugs Analysis Report (2023 Updates): FDA …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Metastatic Colorectal Cancer pipeline constitutes 130+ key companies continuously working towards developing 140+ Metastatic

Metastatic Melanoma Pipeline and Clinical Trials Assessment 2023: FDA Approvals, …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Metastatic Melanoma pipeline constitutes 75+ key companies continuously working towards developing 75+ Metastatic Melanoma

Go To Page:    51 52 53 54 55 56 57 58 59 60